Author:
Vora Sonal,Ghosh Kanjaksha,Shetty Shrimati,Salvi Vinita,Satoskar Purnima
Abstract
Abstract
Background
Deep venous thrombosis (DVT) is an important complication in the peripartal and postpartal period.
Methods
We followed up prospectively the prevalence of DVT in 34720 prenatal mothers between June 2002 and July 2006 attending the antenatal clinics of two major hospitals in Mumbai, India. Thirty two women (0.1%) presented for the first time with symptomatic DVT i.e. 17 in the first trimester, 6 in the second and 9 in the third trimester of pregnancy. Nine had history of fetal loss while in the remaining twenty three there was no history of fetal loss.
Results
The evaluation of both acquired and heritable thrombophilia showed a conglomeration of thrombophilia in this group when compared to 100 normal pregnant women who have given birth to at least one healthy baby with no history of fetal death, DVT or other obstetrical complications. The relative risks for all the antiphospholipid antibodies (APA) studied i.e lupus anticoagulant (LA), IgG/IgM antibodies for cardiolipin (ACA), β2 glycoprotein 1 (β2 GP 1) and annexin V were significantly higher in women with pregnancy associated DVT (RR 7.4 95% CI 4.3–11.3 P < 0.05). Among the genetic thrombophilia markers studied, Protein S (PS) deficiency was the strongest risk factor (RR 5.00 95% CI 3.02–5.00 P < 0.05) followed by factor V Leiden (FVL) mutation (RR 4.57 95% CI 2.23–4.57 P < 0.05) and PAI 4G/4G homozygosity (RR 3.24 95% CI 1.85–5.12 P < 0.05). Protein C (PC) and endothelial protein C receptor (EPCR) 23 bp insertion polymorphism was also increased in the patient group as compared to controls but the difference was not statistically significant. The MTHFR C677T, fibrinogen gene β448 Arg/Lys polymorphisms were not significantly different from the normal controls, while antithrombin III (AT III) deficiency and PT G20210A polymorphism were absent in both controls and patients. Two or more risk factors were present in 22 out of 32 cases (68.75%).
Conclusion
We conclude that the prevalence of DVT in India is more or less similar to other reports published and both acquired and heritable thrombophilia show strong association with DVT associated with pregnancy.
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. National Institutes of Health Consensus Development Conference: Prevalence of venous thrombosis and embolism. JAMA 1986, 256: 744-749. 10.1001/jama.256.6.744
2. Greer IA: Haemostasis and thrombosis in pregnancy. Haemostasis and Thrombosis. Volume 2. Edited by: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD. Edinburg, Scotland: Churchil Livingstone; 1994:987-1015.
3. Bonnar J: Hemostasis and coagulation disorders in pregnancy. Hemostasis and Thrombosis. 2nd edition. Edited by: Bloom AL, Thomas DP. Edinburgh, Scotland: Churchill Livingstone; 1987:570-584.
4. Uszynski M, Maciejewski K, Uszynski W, Kuczynski J: Placenta and myometrium – the two main sources of fibrinolytic components during pregnancy. Gynaecol Obstet Invest 2001, 52: 189-193. 10.1159/000052971
5. Simpson EL, Lawrenson RA, Nightingale AL, Farmer RD: Venous thromboembolism in pregnancy and puerperium: incidence and additional risk factors from a London perinatal database. Brit J Obstet Gynaecol 2001, 108: 56-60. 10.1016/S0306-5456(00)00004-8
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献